Concepts of advanced therapeutic delivery systems for the management of remodeling and inflammation in airway diseases

Author:

Dhanjal Daljeet Singh1ORCID,Sharma Parvarish2ORCID,Mehta Meenu3ORCID,Tambuwala Murtaza M4ORCID,Prasher Parteek5ORCID,Paudel Keshav R6ORCID,Liu Gang6ORCID,Shukla Shakti D3ORCID,Hansbro Philip M6ORCID,Chellappan Dinesh Kumar7ORCID,Dua Kamal3ORCID,Satija Saurabh2ORCID

Affiliation:

1. School of Bioengineering & Biosciences, Lovely Professional University, Phagwara, Punjab, 144411, India

2. School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India

3. Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, 2007, Australia

4. School of Pharmacy & Pharmaceutical Sciences, Ulster University, Coleraine, County, Londonderry, BT52 1SA, Northern Ireland, UK

5. Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, 248007, India

6. Centre for Inflammation, Centenary Institute & University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia

7. Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia

Abstract

Chronic respiratory disorders affect millions of people worldwide. Pathophysiological changes to the normal airway wall structure, including changes in the composition and organization of its cellular and molecular constituents, are referred to as airway remodeling. The inadequacy of effective treatment strategies and scarcity of novel therapies available for the treatment and management of chronic respiratory diseases have given rise to a serious impediment in the clinical management of such diseases. The progress made in advanced drug delivery, has offered additional advantages to fight against the emerging complications of airway remodeling. This review aims to address the gaps in current knowledge about airway remodeling, the relationships between remodeling, inflammation, clinical phenotypes and the significance of using novel drug delivery methods.

Publisher

Future Science Ltd

Subject

Drug Discovery,Pharmacology,Molecular Medicine

Reference172 articles.

1. World Health Organization. Projections of mortality and causes of death, 2015 and 2030. https://knowledge4policy.ec.europa.eu/visualisation/top-causes-death-global-projections-mortality-causes-death-2015-2030_en

2. Projections of Global Mortality and Burden of Disease from 2002 to 2030

3. Celastrol-loaded liquid crystalline nanoparticles as an anti-inflammatory intervention for the treatment of asthma

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3